Inhaled prostacyclin (PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit

Canadian Journal of Anesthesia

Volumn 48, Issue 9, 2001, Pages 924-929

  Haché, Manon ^a   Denault, André ^a   Bélisle, Sylvain ^a   Couture, Pierre ^a   Babin, Denis ^a   Tétrault, Francine ^b   Guimond, Jean Gilles ^b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTERIAL GAS; ARTICLE; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; FEMALE; HEMODYNAMICS; HOSPITALIZATION; HUMAN; HYPOTENSION; HYPOXIA; INTENSIVE CARE UNIT; LUNG ARTERY PRESSURE; LUNG PRESSURE; MALE; MORTALITY; NEBULIZER; OPERATING ROOM; OXYGENATION; PNEUMOTHORAX; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; VASODILATATION; ANOXIA; DRUG EFFECT; INHALATIONAL DRUG ADMINISTRATION; LENGTH OF STAY; MIDDLE AGED; PEROPERATIVE CARE;

ADMINISTRATION, INHALATION; ADULT; AGED; ANOXIA; ANTIHYPERTENSIVE AGENTS; EPOPROSTENOL; FEMALE; HEMODYNAMIC PROCESSES; HOSPITAL MORTALITY; HUMANS; HYPERTENSION, PULMONARY; INTENSIVE CARE UNITS; INTRAOPERATIVE CARE; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0034747517     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03017361     Document Type: Article

References (25)

1. Prostacyclin is a circulating hormone
2. 1: Molecular mechanisms and therapeutic utility
3. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis
4. Aerosolised prostacyclin in adult respiratory distress syndrome
5. Report of the American-European Consensus conference on acute respiratory distress syndrome: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee
6. 2) in acute respiratory distress syndrome: Impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response
7. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension
8. 2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction
9. Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets
10. Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction
11. Effects of inhaled nitric oxide and nebulized prostacyclin on hypoxic pulmonary vasoconstriction in anesthetized sheep
12. Efficacy of inhaled prostanoids in experimental pulmonary hypertension
13. Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension
14. Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome
15. Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma
16. Pulmonary and antiaggregatory effects of prostacyclin after inhalation and intravenous infusion
17. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension
18. Effects of aerosolized prostacyclin in severe pneumonia. Impact of fibrosis
19. Inhaled nitric oxide: Clinical applications, indications, and toxicology
20. 2) versus inhaled nitric oxide in adult respiratory distress syndrome
21. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension
22. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance
23. Effect of low concentrations of prostacyclin on platelet function in vitro
24. Pulmonary deposition of a nebulised aerosol during mechanical ventilation
25. Aerosol delivery in intubated, mechanically ventilated patients